Streetbeat News

Stock Prices

LNG

Cheniere Energy's CEO Jack Fusco reported that the January freeze posed significant production challenges for the company, impacting its ability to meet commercial commitments. This situation could affect the company's short-term operational efficiency and financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:28 pm

NOVA

Sunnova Energy International's shares surged following the announcement of better-than-expected Q1 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:28 pm

OMI

Owens & Minor's shares are trading lower despite the company reporting earnings for Q1 that exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:27 pm

GSIT

GSI Technology's shares have declined following the announcement of a year-over-year decrease in their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:25 pm

AMD

NVDA

SMCI

Nvidia Corporation (NASDAQ:NVDA) is experiencing contrasting opinions with analysts maintaining a bullish stance, projecting a price target of $949.36, while Reddit users predict a drop to $800 due to market trends and supply chain issues. Technical indicators support a bullish outlook, but concerns over supply chain constraints, similar to those faced by Super Micro Computer Inc (NASDAQ:SMCI) and Advanced Micro Devices Inc (NASDAQ:AMD), fuel bearish predictions from Reddit.

Portfolio Pulse from Surbhi Jain

May 03, 2024 | 3:24 pm

AMGN

Amgen Inc (NASDAQ:AMGN) reported Q1 earnings with an adjusted EPS of $3.96, surpassing the consensus estimate of $3.87. Sales rose 22% Y/Y to $7.45 billion, beating estimates. The company forecasts full-year 2024 adjusted EPS of $19-$20.20, against a consensus of $19.48. Amgen is discontinuing AMG 786, an obesity drug candidate, to focus on MariTide, which is seen as a potential standout therapy. William Blair upgraded Amgen to Outperform, citing confidence in MariTide's efficacy and safety. Despite competition from Novo Nordisk and Eli Lilly, MariTide is expected to significantly impact Amgen's share prices positively.

Portfolio Pulse from Vandana Singh

May 03, 2024 | 3:24 pm

BKNG

JP Morgan analyst Doug Anmuth maintains an Overweight rating on Booking Holdings (NASDAQ:BKNG) and raises the price target from $3950 to $4025.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:23 pm

BENF

Shares of Beneficient (BENF) were halted on a circuit breaker due to a significant upside movement, with the stock now up 290.6%.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:22 pm

BFAM

Bright Horizons Family shares surged following the announcement of their Q1 2024 earnings, which exceeded analysts' expectations for both adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 3:19 pm

SHLS

Shoals Technologies Group saw significant options activity with a sweep of 547 June 21 $10 calls at $0.7, compared to an open interest of 165. This activity occurred as the stock traded near $9.005, ahead of their earnings report on May 7.

Portfolio Pulse from Charles Gross

May 03, 2024 | 3:15 pm